Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Marshall University.
Recruitment status was Active, not recruiting
Information provided by:
First received: December 26, 2007
Last updated: January 9, 2008
Last verified: December 2007
At this time, Saint Mary's Medical Center is currently in the process of implementing a standardized diabetic ketoacidosis (DKA) protocol. The first main goal of this project will be to evaluate patient outcomes to determine the effects of treating patients without a standardized protocol and to establish a baseline on how patients are being treating with DKA. The final goal of the project will be to compare outcomes of those patients not placed on the protocol to those that were treated using SMMC newly implemented DKA protocol. The overall goal of this project is to determine the benefit of an institutional DKA protocol.
||Time Perspective: Retrospective
||Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
Primary Outcome Measures:
- Hospital length of stay [ Time Frame: Time in hospital ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- ICU length of stay [ Time Frame: hospital stay ] [ Designated as safety issue: No ]
- ICU length of stay Hypoglycemic events (BG<60) [ Time Frame: hospital stay ] [ Designated as safety issue: No ]
- Time to correction of glucose level and anion gap [ Time Frame: hospital stay ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||July 2008 (Final data collection date for primary outcome measure)
Patients treated for DKA under DKA protocol implemented by hospital
To establish a baseline on how patients are being treating with DKA in general and without a standardized DKA protocol
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Those patients admitted to St. Mary's Medical Center with a diagnosis of DKA.
- Admitted to St. Mary's Medical Center with DKA
- >/= 18 years of age
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00589680
|St. Mary's Medical Center
|Huntington, West Virginia, United States, 25702 |
||Sharon Jones, Pharm.D.
||St. Mary's Medical Center
No publications provided
||Sharon E. Jones, Pharmacy Clinical Coordinator/Residency Director, St. Mary's Medical Center
History of Changes
|Other Study ID Numbers:
|Study First Received:
||December 26, 2007
||January 9, 2008
||United States: Institutional Review Board
Keywords provided by Marshall University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 24, 2014
Endocrine System Diseases
Glucose Metabolism Disorders